Martin Zimmermann

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi et al. · Blood · 2010 · 786 citations · Full text

Medicine, Hematology, Oncology +11

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Anja Möricke, Alfred Reiter, Martin Zimmermann et al. · Blood · 2008 · 610 citations · Full text

Medicine, Oncology, Pediatrics +14

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

Martin Schrappe, Alfred Reiter, Wolfgang Ludwig et al. · PubMed · 2000 · 609 citations

Medicine, Oncology, Pediatrics +17

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study

Brian V. Balgobind, Susana C. Raimondi, Jochen Harbott et al. · Blood · 2009 · 447 citations · Full text

Medicine, Hematology, Oncology +14

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

Martin Schrappe, Maria Grazia Valsecchi, Claus R. Bartram et al. · Blood · 2011 · 438 citations · Full text

Life Sciences, Immunology, Immunotherapy +3